InvestSMART

Bioxyne Limited (ASX: BXN) - Share Price

Current share price for BXN : $0.930 0.01 (1.06%)+

BXN General Information +

ASX Code BXN
Website N/A
Industry/Sector n/a
Market Cap ($M) 213
BXN Share Price $0.930
Day High $0.960
Day Low $0.910
Last Close $0.940
BXN Share Price Movement $0.01 ( 1.06% )
Prices as at 16:40, 6 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Bioxyne Limited (BXN) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Bioxyne Limited (BXN) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Bioxyne Limited (BXN) price-sensitive announcements

BXN - Notice of General Meeting/Proxy Form
The document is a Notice of General Meeting for Bioxyne Limited, scheduled for 19 June 202
Bioxyne Limited (BXN)
21 May 2026 | 5:38 PM
BXN - Secures $50m Exclusive German Supply Agreement with ADREX
Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a two-year, $50
Bioxyne Limited (BXN)
12 May 2026 | 8:22 AM
BXN - Expands LATAM Footprint First Supply Agreement Costa Rica
Bioxyne Limited, through its subsidiary Breathe Life Sciences, has expanded its supply agr
Bioxyne Limited (BXN)
11 May 2026 | 8:24 AM
BXN - Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Limited, an Australian pharmaceutical company, reported significant financial impr
Bioxyne Limited (BXN)
21 Apr 2026 | 8:33 AM

Bioxyne Limited (BXN) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Bioxyne Limited (BXN)
ORDINARY FULLY PAID
Consumer Staple $214 Appendix 3H 3 Jul 2026 12:27PM $0.925 $0.930 risen by 0.54%
Bioxyne Limited (BXN)
ORDINARY FULLY PAID
Consumer Staple $214 Appendix 2A 3 Jul 2026 10:19AM $0.910 $0.930 risen by 2.20%
Bioxyne Limited (BXN)
ORDINARY FULLY PAID
Consumer Staple $214 Change of Name - BLS Pharmaceuticals Limited 29 Jun 2026 10:08AM $0.940 $0.930 fallen by 1.06%
Bioxyne Limited (BXN)
ORDINARY FULLY PAID
Consumer Staple $214 Application for quotation of securities - BXN 19 Jun 2026 5:31PM $0.105 $0.930 risen by 785.71%
Bioxyne Limited (BXN)
ORDINARY FULLY PAID
Consumer Staple $214 Results of Meeting 19 Jun 2026 3:42PM $0.110 $0.930 risen by 745.45%
Bioxyne Limited (BXN)
ORDINARY FULLY PAID
Consumer Staple $214 Bioxyne General Meeting 19.6.2026 18 Jun 2026 3:07PM $0.098 $0.930 risen by 848.98%

Bioxyne Limited (BXN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
12 May 2026 HO, Anthony (Tony) Buy Indirect Shares 5,000,000 $0.020 $100,000.000
12 May 2026 HO, Anthony (Tony) Exercise Options 5,000,000 $0.020 $100,000.000
19 Mar 2026 WATSON, Samuel Buy Indirect Shares 1,800,000 $0.050 $90,000.000

See all changes in directors' interest & trades for Bioxyne Limited (BXN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.